"The INITIATE team puts in significant time and resources to help build companies right from the beginning. Together, we developed the idea for how to fix the pervasive industry problem of poor quality medical data. The ideas became a product, and the product became a company."
Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage
Precision research clinical platform is designed to efficiently bring life-saving treatments to market at scale faster than ever before while providing equitable access to care; Company raises $6 million in seed funding from leading VCs
Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, announces the promotion of Jenn Buechel to the new role of President & Chief Operating Officer.